SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001685071-19-000007
Filing Date
2019-03-05
Accepted
2019-03-05 07:11:17
Documents
3
Period of Report
2019-03-05
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K dovaq42018form8-kearningsr.htm 8-K 23149
2 EXHIBIT 99.1 dovaq42018earningsrelease.htm EX-99.1 124670
3 dovaq32018earningsrel_image1.gif GRAPHIC 42179
  Complete submission text file 0001685071-19-000007.txt   207245
Mailing Address 240 LEIGH FARM ROAD DURHAM NC 27707
Business Address 240 LEIGH FARM ROAD DURHAM NC 27707 919-806-4487
Dova Pharmaceuticals Inc. (Filer) CIK: 0001685071 (see all company filings)

IRS No.: 813858961 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38135 | Film No.: 19656589
SIC: 2834 Pharmaceutical Preparations